Compass Pathways CEO Kabir Nath says company will go slow before going fast on COMP360 launch
Compass Pathways CEO: Psychedelics company will ‘go slow before we go fast’
Compass Pathways chief executive Kabir Nath said the company will "go slow before we go fast" as it prepares to complete a rolling FDAFDAThe Food and Drug Administration, the United States regulator of medicines, medical devices and food.Open the glossary submission this quarter for COMP360.
Key facts
- Kind of item
- Analysis and opinion
- Compound
- Psilocybin
- Condition
- Depression
- Organisation
- Compass Pathways
- Jurisdiction
- United States
- Source
- STAT: psychedelics (statnews.com)
- Published
- Original
- Read it at statnews.com
How this summary was made
The summary was written by an AI model from the linked source, and a model scored the item against this site's editorial criteria. The facts above come from the item's topics and from identifiers written out in the stored text. Anything not found there is left out, so a missing row means not stated, not no. Read the original before relying on any detail. Editorial method
Source: STAT: psychedelics · statnews.com
Connected to
- Kind of item
- Analysis and opinion
- Compound
- Psilocybin
- Condition
- Depression
- Organisation
- Compass Pathways
- Jurisdiction
- United States